IIT Delhi study reveals mechanisms driving SARS-CoV-2 evolution in humans

IIT Delhi researchers have published a study revealing the evolution of SARS-CoV-2 in humans, helping get a better insight into Covid-19 immunity

coronavirus
Photo: Bloomberg
PTI
2 min read Last Updated : May 29 2022 | 5:43 PM IST
Researchers at the Indian Institute of Technology (IIT), Delhi have revealed the mechanisms driving the evolution of SARS-CoV-2 in humans which can help in better understanding of COVID-19's pathogenesis, immune evasion and emergence of variants of concern.
According to the seven-member research team, CpG (a cytosine followed by a guanine) numbers in virus genomes have been linked to host-switching, the efficiency of virus replication, immune evasion and the ability of a virus to cause disease.
The researchers found that the rate of CpG depletion from SARS-CoV-2 genomes rapidly decreases after the first few months of evolution in humans. The research has been published in a journal, Molecular Biology and Evolution, and is titled "The Slowing Rate of CpG Depletion in SARS-CoV-2 Genomes is Consistent with Adaptations to the Human Host".
"Zinc-finger antiviral protein (ZAP) is a host protein that can bind to CpG-rich regions in SARS-CoV-2, the causative agent of the COVID-19 pandemic, and recruits other host proteins to degrade the viral RNA. Several viruses including HIV-1, Influenza A virus and SARS-CoV-2 prefer to reduce their CpG content (by losing CpGs) to minimise the host immune response, thus allowing better virus replication and survival," Vivekanandan Perumal from the Kusuma School of Biological Sciences, IIT Delhi told PTI.
"The team analysed over 1.4 million full-length SARS-CoV-2 sequences from across the world. They found that the rate of CpG depletion from SARS-CoV-2 genomes rapidly decreases after the first few months of evolution in humans.
"Furthermore, most SARS-CoV-2 variants of concern had lower CpG content. This work highlights the existence of selection pressures apart from ZAP that may lead to CpG depletion in SARS-CoV-2 genomes," he added.
SARS-CoV-2 has a uracil-rich (uracil is one of the four building blocks of RNA) genome. The researchers have identified how uracils adjacent to CpGs contribute to the accelerated loss of CpGs from SARS-CoV-2 genomes.
"Our results lay the necessary groundwork for future studies on understanding the intricacies of virus-host interactions leading to CpG depletion," IIT Delhi professor Manoj Menon said.
"We observed that the extent of CpG depletion in SARS-CoV-2 genomes is modest during the first 17 months of the pandemic corresponding to over 170 million documented human infections," he said. 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story